About the Authors
- Heiner Wedemeyer
-
* E-mail: wedemeyer.heiner@mh-hannover.de
Affiliation Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School, Hannover, Germany
- Xavier Forns
-
Affiliation Liver Unit, Hospital Clinic, IDIBAPS and CIBEREHD, Barcelona, Spain
- Christophe Hézode
-
Affiliation Department of Hepatology and Gastroenterology, Hôpital Henri Mondor, INSERM U955, Université Paris-Est, Créteil, France
- Samuel S. Lee
-
Affiliation Liver Unit, University of Calgary, Calgary, Canada
- Astrid Scalori
-
Affiliation Global Product Development Immunology, Respiratory, Roche Products Ltd, Welwyn, United Kingdom
- Athina Voulgari
-
Affiliation Global Product Development Clinical Science, Roche Products Ltd, Welwyn, United Kingdom
- Sophie Le Pogam
-
Affiliation Clinical Development-Infectious Diseases, Genentech Inc., South San Francisco, California, United States of America
- Isabel Nájera
-
Affiliation Roche Pharma and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland
- James A. Thommes
-
Affiliation Product Development Immunology, Genentech Inc., South San Francisco, California, United States of America
Competing Interests
HW: has served as a consultant/speaker for Abbott, AbbVie, Biolex, BMS, Boehringer Ingelheim, Gilead Sciences, ITS, J&J/Janssen-Cilag, Medgenics, Merck/Schering-Plough, Novartis, Roche, Roche Diagnostics, Siemens, Transgene, ViiV; and has received research grants from Abbott, BMS, Gilead Sciences, Merck, Novartis, Roche, Roche Diagnostics, Siemens. XF: has received unrestricted grant support from Janssen and has served as an advisor for Janssen, Gilead and AbbVie. CH: has served as a consultant/speaker for Roche, Bristol-Myers Squibb, Merck, Janssen, AbbVie, and Gilead Sciences. SSL: Consulting for or research funding from: AbbVie, Achillion, Bristol Myers Squibb, Debiopharm, Gilead Sciences, GlaxoSmithKline, Janssen, Merck, Novartis, Roche, Vertex. Speakers Bureau: Bristol Myers Squibb, Gilead Sciences, Janssen, Merck, Roche, Vertex. AS: Employee of Roche Products Ltd. AV: Employee of Roche Products Ltd. SLP: Employee of Genentech Inc. IN: Employee of F. Hoffmann-La Roche Ltd. JAT: Employee of Genentech Inc. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: HW XF AS AV IN JAT. Performed the experiments: HW CH SL AS AV JAT. Analyzed the data: HW XF CH SL AS AV SLP IN JAT. Contributed reagents/materials/analysis tools: HW AV JAT. Wrote the paper: HW XF CH SL AS AV SLP IN JAT.